Proteomic and metabolomic characterization of bone, liver, and lung metastases in plasma of breast cancer patients

CONCLUSIONS: For bone metastasis, biomarkers such as leucyl-tryptophan, LysoPC(P-16:0/0:0), FN1, and HSPG2 have been validated. dUDP, LPE(18:1/0:0), and aspartylphenylalanine have been confirmed for liver metastasis. For lung metastasis, dUDP, testosterone sulfate, and PE(14:0/20:5) have been established.PMID:38571380 | DOI:10.1002/prca.202300136

Source: Clinical Breast Cancer - April 4, 2024 Category: Cancer & Oncology Authors: Hui Ye Xiabo Shen Yaohan Li Weibin Zou Syed Shams Ul Hassan Yue Feng Xiaojia Wang Jingkui Tian Xiying Shao Yi Tao Wei Zhu Source Type: research